20 (AIDX) Accounts Payables (2024 - 2026)

20's (AIDX) quarterly Accounts Payables came in at $980486.0 in Q1 2026, up 12.89% on a QoQ basis from $868545.0 in Q4 2025.

20 (AIDX) Accounts Payables (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Accounts Payables data on file, last reported at $980486.0 in Q1 2026.

Quarterly Accounts Payables changed N/A year-over-year to $980486.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $980486.0 (changed N/A YoY) and the FY2025 annual result came in at $868545.0, up 133.29% from the prior year.
Accounts Payables advanced to $980486.0 in Q1 2026, from $868545.0 in the prior quarter.
In the past five years, Accounts Payables ranged from a high of $980486.0 in Q1 2026 to a low of $372303.0 in Q4 2024.
A 3-year average of $740444.7 and a median of $868545.0 in 2025 frame the typical range for Accounts Payables.
The widest YoY moves for Accounts Payables: up 133.29% in 2025, down 133.29% in 2025.
Tracing AIDX's Accounts Payables over 3 years: stood at $372303.0 in 2024, then soared by 133.29% to $868545.0 in 2025, then rose by 12.89% to $980486.0 in 2026.
The last three Accounts Payables figures came in at $980486.0 (Q1 2026), $868545.0 (Q4 2025), and $372303.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn	4.79 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn	1.66 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn	2.42 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn	344.10 Mn
10	20	5.60 Mn	1.05 Mn	304,727.00	1.03 Mn

Download Data